LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1996 | 12-1995 | 12-1993 | 12-1992 | 12-1991 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,610 | 19,804 | 7,699 | 12,349 | 12,349 |
| Marketable Securities | 17,620 | 3,847 | 0 | 1,100 | 1,100 |
| Receivables | 4,000 | 0 | 0 | 0 | 0 |
| Other current assets | 1,230 | 213 | 154 | 188 | 188 |
| TOTAL | $29,460 | $23,864 | $7,853 | $13,637 | $13,637 |
| Non-Current Assets | |||||
| PPE Net | 1,360 | 1,925 | 1,819 | 1,306 | 1,306 |
| Other Non-Current Assets | 850 | 586 | 430 | 326 | 326 |
| TOTAL | $2,210 | $2,511 | $2,249 | $1,632 | $1,632 |
| Total Assets | $31,680 | $26,375 | $10,102 | $15,269 | $15,269 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,530 | 738 | 778 | 221 | 221 |
| Accrued Expenses | 1,400 | 398 | 299 | 179 | 179 |
| TOTAL | $3,580 | $1,915 | $1,539 | $400 | $400 |
| Non-Current Liabilities | |||||
| TOTAL | $160 | $892 | $1,625 | $14 | $14 |
| Total Liabilities | $3,740 | $2,807 | $3,164 | $414 | $414 |
| Shareholders' Equity | |||||
| Common Shares | 170 | 140 | 8 | 8 | 8 |
| Retained earnings | -48,370 | -38,777 | -19,910 | -11,963 | -11,963 |
| Other shareholders' equity | -170 | -442 | 56 | 344 | 344 |
| TOTAL | $27,930 | $23,568 | $6,938 | $14,855 | $14,855 |
| Total Liabilities And Equity | $31,670 | $26,375 | $10,102 | $15,269 | $15,269 |